Equities Analysts Set Expectations for IPSC FY2025 Earnings
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Equities researchers at Chardan Capital issued their FY2025 earnings estimates for shares of Century Therapeutics in a report issued on Monday, March 24th. Chardan Capital analyst Y. Livshits forecasts that the company will post earnings per share of ($0.33) for the year. Chardan Capital has a “Buy” […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Equities researchers at Chardan Capital issued their FY2025 earnings estimates for shares of Century Therapeutics in a report issued on Monday, March 24th. Chardan Capital analyst Y. Livshits forecasts that the company will post earnings per share of ($0.33) for the year. Chardan Capital has a “Buy” […]
